SABCS15: Promising phase 1 results lead to phase 2 for ONT-380 in HER2+ breast cancer [Archive]

View Full Version : SABCS15: Promising phase 1 results lead to phase 2 for ONT-380 in HER2+ breast cancer

News

12-10-2015, 06:30 AM

Results of an ongoing phase 1b clinical trial presented at the 2015 San Antonio Breast Cancer Symposium show promise of the experimental anti-cancer agent ONT-380 against metastatic HER2+ breast...

More... (http://www.medicalnewstoday.com/releases/303905.php)